カテゴリ： MarketLine, アメリカ, 企業調査

BioMarin Pharmaceutical Inc.：企業の戦略・SWOT・財務情報

◆英語タイトル：BioMarin Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4471
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：52
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

BioMarin Pharmaceutical Inc. – Strategy, SWOT and Corporate Finance Report
Summary

BioMarin Pharmaceutical Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

BioMarin Pharmaceutical Inc. (BioMarin or ‘the company’), a biotechnology company, develops and commercializes biopharmaceuticals for the treatment of rare diseases and medical conditions. The company manufactures pharmaceuticals for treatment of serious diseases and medical conditions such as Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), phenylketonuria (PKU), achondroplasia, late infantile neuronal ceroid lipofuscinosis (CLN2) and hemophilia A. Its product portfolio consists of products and multiple clinical and preclinical product candidates. The company operates in the US, Europe, Latin America, and other regions of the world. BioMarin is headquartered in San Rafael, California.

Scope

- Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
- An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
- Intelligence on BioMarin Pharmaceutical Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on BioMarin Pharmaceutical Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
BioMarin Pharmaceutical Inc.: Company Overview 9
BioMarin Pharmaceutical Inc.: Overview and Key Facts 9
BioMarin Pharmaceutical Inc.: Overview 9
BioMarin Pharmaceutical Inc.: Key Facts 9
BioMarin Pharmaceutical Inc.: Key Employees 11
BioMarin Pharmaceutical Inc.: Key Employee Biographies 12
BioMarin Pharmaceutical Inc.: Major Products and Services 19
BioMarin Pharmaceutical Inc.: Company History 20
BioMarin Pharmaceutical Inc.: Management Statement 24
BioMarin Pharmaceutical Inc.: Locations and Subsidiaries 26
BioMarin Pharmaceutical Inc.: Key Competitors 27
BioMarin Pharmaceutical Inc.: Company Analysis 28
BioMarin Pharmaceutical Inc.: Business Description 28
BioMarin Pharmaceutical Inc.: SWOT Analysis 30
BioMarin Pharmaceutical Inc.: SWOT Overview 30
BioMarin Pharmaceutical Inc.: Strengths 30
BioMarin Pharmaceutical Inc.: Weaknesses 31
BioMarin Pharmaceutical Inc.: Opportunities 31
BioMarin Pharmaceutical Inc.: Threats 33
BioMarin Pharmaceutical Inc.: Corporate Financial Deals Activity 35
BioMarin Pharmaceutical Inc.: Financial Deals Overview 35
BioMarin Pharmaceutical Inc.: Targets and Partners 37
BioMarin Pharmaceutical Inc.: Top Deals 2014 – 2018YTD* 38
BioMarin Pharmaceutical Inc.: Advisors 39
BioMarin Pharmaceutical Inc.: Top Legal Advisors 39
BioMarin Pharmaceutical Inc.: Top Financial Advisors 39
BioMarin Pharmaceutical Inc.: Mergers and Acquisitions 40
BioMarin Pharmaceutical Inc.: Capital Raising 41
BioMarin Pharmaceutical Inc.: Partnership 42
BioMarin Pharmaceutical Inc.: Recent Developments 43
BioMarin Pharmaceutical Inc.: News and Events Summary 43
BioMarin Pharmaceutical Inc.: Financial Performance 46
BioMarin Pharmaceutical Inc.: Market Developments 47
BioMarin Pharmaceutical Inc.: Research & Development 49
Appendix 50
Contact Us 50
Methodology 50
About MarketLine 51

List of Tables
Table 1: BioMarin Pharmaceutical Inc.: Key Facts
Table 2: BioMarin Pharmaceutical Inc.: Key Employees
Table 3: BioMarin Pharmaceutical Inc.: Locations and Subsidiaries
Table 4: BioMarin Pharmaceutical Inc.: Key Competitors
Table 5: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: BioMarin Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m)
Table 8: BioMarin Pharmaceutical Inc.: Targets and Partners
Table 9: BioMarin Pharmaceutical Inc.: Top Deals 2014 - 2018YTD*
Table 10: BioMarin Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: BioMarin Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: BioMarin Pharmaceutical Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: BioMarin Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: BioMarin Pharmaceutical Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: BioMarin Pharmaceutical Inc.: News and Events Summary
Table 19: BioMarin Pharmaceutical Inc.: Financial Performance
Table 20: BioMarin Pharmaceutical Inc.: Market Developments
Table 21: BioMarin Pharmaceutical Inc.: Research & Development



★海外企業調査レポート[BioMarin Pharmaceutical Inc.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Sonic Healthcare Ltd (SHL)：企業の財務・戦略的SWOT分析
    Sonic Healthcare Ltd (SHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Hitachi Zosen Corporation：企業の戦略・SWOT・財務分析
    Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report Summary Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Mitsubishi Tanabe Pharma Corporation：企業の戦略・SWOT・財務情報
    Mitsubishi Tanabe Pharma Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Tanabe Pharma Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Parion Sciences Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Parion Sciences Inc (Parion Sciences) is a development stage company that provides research, development and commercialization of treatments to improve patient’s innate mucosal surface defenses. The company’s pipeline products include P-1037, a clinical stage ENaC blocker for pulmonary disea …
  • FibroGen Inc (FGEN)：製薬・医療：M&Aディール及び事業提携情報
    Summary FibroGen Inc (FibroGen) is a biotechnology company that discovers, develops and commercializes new therapeutics. The company’s pipeline product portfolio includes FG-4592, an oral small molecule inhibitor of HIF prolyl hydroxylases that is used for the treatment of anemia in chronic kidney d …
  • Isto Biologics-医療機器分野：企業M&A・提携分析
    Summary Isto Biologics (Isto), formerly ISTO Technologies Inc, is an orthobiologics company which manufactures and develops products to treat orthopedic and spine disorders. The company offers solutions in cell therapy and rapid bone healing. Its product portfolio includes InQu, a bone graft extende …
  • United States Lime & Minerals Inc：企業の戦略・SWOT・財務分析
    United States Lime & Minerals Inc - Strategy, SWOT and Corporate Finance Report Summary United States Lime & Minerals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Cognition Therapeutics Inc-製薬・医療分野：企業M&A・提携分析
    Summary Cognition Therapeutics Inc (CogRx) is a drug discovery and development company that discovers and develops small molecule therapeutics. The company uses its proprietary biology and chemistry platforms for the development of novel drug targets and disease modifying therapies for the treatment …
  • Fortum Corporation (FORTUM)：石油・ガス：M&Aディール及び事業提携情報
    Summary Fortum Corp (Fortum) is a clean energy company, which generates, distributes and sells heat and electricity. The company undertakes operation and maintenance of power plants; and offers energy-related services. Fortum's operational assets include hydropower plants, condensing power plants, w …
  • Post Holdings Inc：企業の戦略・SWOT・財務分析
    Post Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Post Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sonoma Pharmaceuticals Inc (OCLS)：企業の財務・戦略的SWOT分析
    Summary Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for ad …
  • Siegfried Holding AG (SFZN)：企業の財務・戦略的SWOT分析
    Siegfried Holding AG (SFZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • ESI Group S.A. (ESI)：企業の財務・戦略的SWOT分析
    ESI Group S.A. (ESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Achema AB：企業の戦略的SWOT分析
    Achema AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • CareDx Inc (CDNA)：企業の製品パイプライン分析2018
    Summary CareDx Inc (CareDx), formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used …
  • Boardriders, Inc：企業の戦略的SWOT分析
    Boardriders, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Al Jaber Group：企業の戦略・SWOT・財務分析
    Al Jaber Group - Strategy, SWOT and Corporate Finance Report Summary Al Jaber Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Skyworks Solutions Inc (SWKS)：企業の財務・戦略的SWOT分析
    Skyworks Solutions Inc (SWKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Chesapeake Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Chesapeake Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Chesapeake Energy Corp (Chesapeake) is an upstream oil and gas company in the US. The company explores for, develops and produces oil and gas from its assets. It has liquid operations in Eagle …
  • Maxim Power Corp. (MXG)：企業の財務・戦略的SWOT分析
    Maxim Power Corp. (MXG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆